High Expression of hTERT and Stemness Genes in BORIS/CTCFL Positive Cells Isolated from Embryonic Cancer Cells

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Alberti, Loredana ^a   Renaud, Stéphanie ^b   Losi, Lorena ^c   Leyvraz, Serge ^a   Benhattar, Jean ^a,d  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d Biopath Lab   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE DEHYDROGENASE ISOENZYME 1; BORIS ANTIGEN; CANCER TESTIS ANTIGEN; HERMES ANTIGEN; MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG; CTCFL PROTEIN, HUMAN; DNA BINDING PROTEIN; SMALL INTERFERING RNA; TELOMERASE; TERT PROTEIN, HUMAN;

ALDH1 GENE; ARTICLE; BORIS GENE; CANCER STEM CELL; CD44 GENE; CELL AGING; CELL ISOLATION; CONTROLLED STUDY; DNA METHYLATION; EMBRYO; EMBRYONAL CARCINOMA; EMBRYONAL CARCINOMA STEM CELL; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE IDENTIFICATION; GENE SILENCING; HELA CELL LINE; HTERT GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; MOLECULAR BEACON; OVARY CARCINOMA; PROMOTER REGION; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CELL PROLIFERATION; EMBRYONIC STEM CELL; GENETIC EPIGENESIS; GENETICS; METABOLISM; MOLECULAR IMAGING; OVARY TUMOR; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; WESTERN BLOTTING;

APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; DNA METHYLATION; DNA-BINDING PROTEINS; EMBRYONIC STEM CELLS; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOLECULAR IMAGING; NEOPLASTIC STEM CELLS; OVARIAN NEOPLASMS; PROMOTER REGIONS, GENETIC; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TELOMERASE; TUMOR CELLS, CULTURED;

EID: 84940458396     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109921     Document Type: Article

References (52)

1. Moon H, Filippova G, Loukinov D, Pugacheva E, Chen Q, et al. (2005) CTCF is conserved from Drosophila to humans and confers enhancer blocking of the Fab-8 insulator. EMBO Rep 6: 165-170.
2. Dunn KL, Davie JR (2003) The many roles of the transcriptional regulator CTCF. Biochem Cell Biol 81: 161-167.
3. Herold M, Bartkuhn M, Renkawitz R (2012) CTCF: insights into insulator function during development. Development 139: 1045-1057.
4. Loukinov DI, Pugacheva E, Vatolin S, Pack SD, Moon H, et al. (2002) BORIS, a novel male germ-line-specific protein associated with epigenetic reprogramming events, shares the same 11-zinc-finger domain with CTCF, the insulator protein involved in reading imprinting marks in the soma. Proc Natl Acad Sci USA 99: 6806-6811.
5. Klenova EM, Morse HC 3rd, Ohlsson R, Lobanenkov VV (2002) The novel BORIS + CTCF gene family is uniquely involved in the epigenetics of normal biology and cancer. Semin Cancer Biol 12: 399-414.
6. de Necochea-Campion R, Ghochikyan A, Josephs SF, Zacharias S, Woods E, et al. (2011) Expression of the epigenetic factor BORIS (CTCFL) in the human genome. J Transl Med 9: 213.
7. Hong JA, Kang Y, Abdullaev Z, Flanagan PT, Pack SD, et al. (2005) Reciprocal binding of CTCF and BORIS to the NY-ESO-1 promoter coincides with derepression of this cancer-testis gene in lung cancer cells. Cancer Res 65: 7763-7774.
8. Vatolin S, Abdullaev Z, Pack SD, Flanagan PT, Custer M, et al. (2005) Conditional expression of the CTCF-paralogous transcriptional factor BORIS in normal cells results in demethylation and derepression of MAGE-A1 and reactivation of other cancer-testis genes. Cancer Res 65: 7751-7762.
9. Kouprina N, Noskov VN, Pavlicek A, Collins NK, Schoppee Bortz PD, et al. (2007) Evolutionary diversification of SPANX-N sperm protein gene structure and expression. PLoS One 2: e359.
10. Woloszynska-Read A, James SR, Song C, Jin B, Odunsi K, et al. (2010) BORIS/CTCFL expression is insufficient for cancer-germline antigen gene expression and DNA hypomethylation in ovarian cell lines. Cancer Immun 10: 6.
11. Kholmanskikh O, Loriot A, Brasseur F, De Plaen E, De Smet C (2008) Expression of BORIS in melanoma: lack of association with MAGE-A1 activation. Int J Cancer 122: 777-784.
12. Renaud S, Loukinov D, Alberti L, Vostrov A, Kwon YW, et al. (2011) BORIS/CTCFL-mediated transcriptional regulation of the hTERT telomerase gene in testicular and ovarian tumor cells. Nucleic Acids Res 39: 862-873.
13. Hiyama E, Hiyama K (2007) Telomere and telomerase in stem cells. Br J Cancer 96: 1020-1024.
14. Shay JW, Wright WE (2011) Role of telomeres and telomerase in cancer. Semin Cancer Biol 21: 349-353.
15. Kim H, Yoo JE, Cho JY, Oh BK, Yoon YS, et al. (2013) Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing ''stemness''-related markers. J Hepatol 59: 746-752.
16. Paranjape AN, Mandal T, Mukherjee G, Kumar MV, Sengupta K, et al. (2012) Introduction of SV40ER and hTERT into mammospheres generates breast cancer cells with stem cell properties. Oncogene 31: 1896-1909.
17. Schepers AG, Vries R, van den Born M, van de Wetering M, Clevers H (2011) Lgr5 intestinal stem cells have high telomerase activity and randomly segregate their chromosomes. EMBO J 30: 1104-1109.
18. Monroy-Contreras R, Vaca L (2011) Molecular beacons: powerful tools for imaging RNA in living cells. J Nucleic Acids 2011: 741723.
19. Rhee WJ, Santangelo PJ, Jo H, Bao G (2008) Target accessibility and signal specificity in live-cell detection of BMP-4 mRNA using molecular beacons. Nucleic Acids Res 36: e30.
20. Arden-Jacob J, Frantzeskos J, Kemnitzer NU, Zilles A, Drexhage KH (2001) New fluorescent markers for the red region. Spectrochim Acta A Mol Biomol Spectrosc 57: 2271-2283.
21. Meerbrey KL, Hu G, Kessler JD, Roarty K, Li MZ, et al. (2011) The pINDUCER lentiviral toolkit for inducible RNA interference in vitro and in vivo. Proc Natl Acad Sci USA 108: 3665-3670.
22. Peixoto A, Monteiro M, Rocha B, Veiga-Fernandes H (2004) Quantification of multiple gene expression in individual cells. Genome Res 14: 1938-1947.
23. Noutsias M, Rohde M, Block A, Klippert K, Lettau O, et al. (2008) Preamplification techniques for real-time RT-PCR analyses of endomyocardial biopsies. BMC Mol Biol 9: 3
24. Pugacheva EM, Suzuki T, Pack SD, Kosaka-Suzuki N, Yoon J, et al. (2010) The structural complexity of the human BORIS gene in gametogenesis and cancer. PLoS One 5: e13872.
25. Renaud S, Pugacheva EM, Delgado MD, Braunschweig R, Abdullaev Z, et al. (2007) Expression of the CTCF-paralogous cancer-testis gene, brother of the regulator of imprinted sites (BORIS), is regulated by three alternative promoters modulated by CpG methylation and by CTCF and p53 transcription factors. Nucleic Acids Res 35: 7372-7388.
26. Wege H, Chui MS, Le HT, Tran JM, Zern MA (2003) SYBR Green real-time telomeric repeat amplification protocol for the rapid quantification of telomerase activity. Nucleic Acids Res 31: E3-3.
27. Medema JP (2013) Cancer stem cells: the challenges ahead. Nat Cell Biol 15: 338-344.
28. Tyagi S, Kramer FR (1996) Molecular beacons: probes that fluoresce upon hybridization. Nat Biotechnol 14: 303-308.
29. Li Y, Zhou X, Ye D (2008) Molecular beacons: an optimal multifunctional biological probe. Biochem Biophys Res Commun 373: 457-461.
30. Larsson HM, Lee ST, Roccio M, Velluto D, Lutolf MP, et al. (2012) Sorting live stem cells based on Sox2 mRNA expression. PLoS One 7: e49874.
31. King FW, Liszewski W, Ritner C, Bernstein HS (2011) High-throughput tracking of pluripotent human embryonic stem cells with dual fluorescence resonance energy transfer molecular beacons. Stem Cells Dev 20: 475-484.
32. Teshima S, Shimosato Y, Hirohashi S, Tome Y, Hayashi I, et al. (1988) Four new human germ cell tumor cell lines. Lab Invest 59: 328-336.
33. Hanahan D,Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144: 646-674.
34. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, et al. (1994) Specific association of human telomerase activity with immortal cells and cancer. Science 266: 2011-2015.
35. Domont J, Pawlik TM, Boige V, Rose M, Weber JC, et al. (2005) Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis. J Clin Oncol 23: 3086-3093.
36. Gertler R, Rosenberg R, Stricker D, Friederichs J, Hoos A, et al. (2004) Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma. J Clin Oncol 22: 1807-1814.
37. Terrin L, Rampazzo E, Pucciarelli S, Agostini M, Bertorelle R, et al. (2008) Relationship between tumor and plasma levels of hTERT mRNA in patients with colorectal cancer: implications for monitoring of neoplastic disease. Clin Cancer Res 14: 7444-7451.
38. Tabori U, Ma J, Carter M, Zielenska M, Rutka J, et al. (2006) Human telomere reverse transcriptase expression predicts progression and survival in pediatric intracranial ependymoma. J Clin Oncol 24: 1522-1528.
39. Vicente-Duenas C, Barajas-Diego M, Romero-Camarero I, Gonzalez-Herrero I, Flores T, et al. (2012) Essential role for telomerase in chronic myeloid leukemia induced by BCR-ABL in mice. Oncotarget 3: 261-266.
40. Marian CO, Wright WE, Shay JW(2010) The effects of telomerase inhibition on prostate tumor-initiating cells. Int J Cancer 127: 321-331.
41. Marian CO, Cho SK, McEllin BM, Maher EA, Hatanpaa KJ, et al. (2010) The telomerase antagonist, imetelstat, efficiently targets glioblastoma tumor-initiating cells leading to decreased proliferation and tumor growth. Clin Cancer Res 16: 154-163.
42. Przyborski SA, Christie VB, Hayman MW, Stewart R, Horrocks GM (2004) Human embryonal carcinoma stem cells: models of embryonic development in humans. Stem Cells Dev 13: 400-408.
43. Sperger JM, Chen X, Draper JS, Antosiewicz JE, Chon CH, et al. (2003) Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci USA 100: 13350-13355.
44. Monk M, Hitchins M, Hawes S (2008) Differential expression of the embryo/cancer gene ECSA(DPPA2), the cancer/testis gene BORIS and the pluripotency structural gene OCT4, in human preimplantation development. Mol Hum Reprod 14: 347-355.
45. John T, Caballero OL, Svobodova SJ, Kong A, Chua R, et al. (2008) ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancer. Clin Cancer Res 14: 3291-3298.
46. Campisi J, d'Adda di Fagagna F (2007) Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol 8: 729-740.
47. Sager R (1991) Senescence as a mode of tumor suppression. Environ Health Perspect 93: 59-62.
48. Campisi J (2001) Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol 11: S27-31.
49. Campisi J (2013) Aging, cellular senescence, and cancer. Annu Rev Physiol 75: 685-705.
50. Dimri GP, Lee X, Basile G, Acosta M, Scott G, et al. (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 92: 9363-9367.
51. Hahn WC, Stewart SA, Brooks MW, York SG, Eaton E, et al. (1999) Inhibition of telomerase limits the growth of human cancer cells. Nat Med 5: 1164-1170.
52. Zhang X, Mar V, Zhou W, Harrington L, Robinson MO (1999) Telomere shortening and apoptosis in telomerase-inhibited human tumor cells. Genes Dev 13: 2388-2399.